A thrombus is a blood clot that forms inside a vessel and stays attached where it formed. An embolus is a mass that has broken loose and is travelling through the bloodstream until it lodges somewhere narrower. Often they are the same clot at two stages. Fibrinogen Activity is one clotting protein a blood panel can measure.
The rest of this guide walks through how each one forms, where they travel, what raises the chance of either happening, how clinicians look for them, and which blood markers describe clotting tendency rather than clotting events.
A thrombus is a blood clot that forms inside a blood vessel or a heart chamber and stays attached to the spot where it developed.
Clotting itself is a normal repair system. When a vessel wall is injured, platelets stick to the exposed surface and clump together, and a chain of clotting proteins converts circulating fibrinogen into fibrin, a sticky mesh of strands that locks the platelet plug in place and traps red blood cells inside it. That plug is what stops bleeding from a cut. A thrombus is the same process happening inside an intact vessel, where nothing needs plugging, or continuing past the point where it should have switched off.
Three conditions are classically described as the drivers of deep vein thrombosis: blood flow that slows or stagnates, injury or activation of the vessel lining, and blood that clots more readily than it should 1. Research suggests that the vein wall and immune cells play an active part in building a venous thrombus, rather than a clot simply settling out of still blood 1.
The word you will see on a report is thrombosis, meaning the process of forming a thrombus. Where it forms shapes what it does. A thrombus in a deep leg vein obstructs drainage, so the leg swells. A thrombus on a damaged artery wall blocks supply, so the tissue downstream starves of oxygen. Either way, while it stays put, the trouble stays local.
An embolus is any mass that travels through the bloodstream away from where it started and wedges in a vessel too narrow to let it pass.
The word comes from a Greek term for a plug or stopper, which is exactly what it does. The defining feature is movement. A thrombus is defined by staying; an embolus is defined by going. That is the whole distinction, and everything else follows from it.
Most emboli are fragments of a thrombus that have detached, which is why you will often see the combined word thromboembolus. Other materials can behave the same way. Fat globules can enter the circulation after a major long bone fracture. Air can enter through an open vein or a line. Clumps of tumour cells, pieces of infected tissue from a heart valve, cholesterol debris from a ruptured plaque and fragments of foreign material can all travel and lodge.
The event itself is called an embolism, and it is usually named after where the plug lands rather than where it came from. A clot that formed in a calf vein and ended up in a lung artery is called a pulmonary embolism, not a calf embolism. Deep vein thrombosis and pulmonary embolism are described as two expressions of a single condition, venous thromboembolism 2. So the two terms are not rivals. One names the clot at rest, the other names the clot in transit.
A thrombus becomes an embolus when part or all of it detaches from the vessel wall and is carried off by flowing blood.
A venous thrombus is not a solid cork. It often has a tail extending into the moving column of blood, and that tail is the part most exposed to shear. At the same time, the body's own clot breakdown system is constantly chewing at the clot's edges, which can loosen its grip on the vein wall. A change in pressure or flow, standing up after a long period of stillness, straining, or simply walking again after surgery can be enough for a fragment to let go.
Once loose, the fragment travels with the current until the plumbing narrows. From a leg or pelvic vein, blood flows up to the right side of the heart and straight out into the pulmonary arteries, which branch into progressively smaller vessels, so that is where a venous embolus almost always stops. Most pulmonary emboli originate from thrombi in the deep veins of the legs or pelvis that break loose and reach the lung circulation 3.
Arterial clots follow a different map. Blood leaving the left side of the heart goes out to the brain, limbs and organs, so an embolus from a heart chamber or a large artery can land in a brain artery, a leg artery or the vessels supplying the gut or a kidney.
The clearest way to hold the difference is a direct comparison of where each one sits, what it is made of and how it shows up.
| Feature | Thrombus | Embolus |
|---|---|---|
| What it is | A clot that forms inside a vessel and remains attached at that site | A mass travelling in the bloodstream that lodges in a narrower vessel |
| Movement | Stationary where it formed | Mobile, by definition |
| Usual composition | Platelets, fibrin strands and trapped blood cells | Most often a detached piece of thrombus, sometimes fat, air, tumour tissue, infected material or foreign debris |
| Where problems appear | At the clot or in the tissue just downstream of it | At a distant site, wherever it finally lands |
| Common examples | Deep vein thrombosis, clot forming on a damaged artery wall | Pulmonary embolism, embolic stroke, sudden limb artery blockage |
| Typical onset of symptoms | Often builds over hours to days | Usually abrupt |
| How it is looked for | Imaging of the suspected vessel, such as ultrasound of the leg veins | Imaging of the destination organ, such as a CT scan of the lung arteries |
| The matching term | Thrombosis, the process of forming one | Embolism, the event of one lodging |
One clot can occupy both columns within a single day. That is not a contradiction in the terms, it is the natural history of the thing.
Venous clots usually begin in the deep veins of the calf, thigh or pelvis, and when they travel they end up in the lungs; arterial clots usually begin in the heart or on a damaged artery wall, and when they travel they end up in the brain, a limb or an abdominal organ.
On the venous side, the classic starting points are the valve pockets of calf veins, where flow is slowest and blood can pool, particularly during long periods of immobility, after surgery or during a hospital stay. A clot may stay in the calf, extend upward into the thigh and pelvic veins, or shed a fragment. The entire venous return funnels through the right heart into the lungs, which act as a filter, so the lung circulation is the destination for venous emboli.
On the arterial side, the common origins are a heart chamber whose rhythm has become irregular so blood eddies instead of emptying cleanly, a heart valve, and the surface of a ruptured cholesterol plaque in a large artery such as the carotid or the aorta. Because arterial blood is heading outward to the body, these emboli lodge wherever the branch gets too small, producing a stroke, a suddenly cold and painful limb, or pain from a starved segment of bowel or kidney.
There is one crossover route. In some people a small communication between the heart's upper chambers allows a venous clot to slip into the arterial side instead of being filtered by the lungs, which is called a paradoxical embolism. It is uncommon, and it is a finding for a cardiologist to assess rather than something to self-diagnose.
No, venous and arterial clots differ in composition, in the conditions that create them and in what they do, even though both are clots.
Venous clots form in slow, low pressure flow. They are rich in fibrin and trapped red blood cells, which is why pathologists describe them as red clots, and they tend to grow along the vein rather than blocking a single point. Slowed flow, vessel wall activation and a heightened clotting tendency are the recognised contributors on this side 1.
Arterial clots form in fast, high pressure flow, usually at the moment a cholesterol plaque in the artery wall cracks open and exposes material that platelets stick to instantly. These are platelet-rich, so they are described as white clots, and they can occlude a vessel in minutes.
The practical consequence is that the two sides have overlapping but distinct risk profiles. Immobility, surgery, cancer and inherited clotting tendencies weigh heavily on the venous side. Arterial events track more closely with the long-running wear on artery walls. That matters when you look at your bloodwork, because a clotting protein result and a cholesterol panel are telling you about related but separate problems, and neither one on its own predicts an event.
It matters because a thrombus causes symptoms where it sits, while an embolus causes symptoms somewhere else entirely, and usually faster.
A deep vein thrombosis typically announces itself in one leg: swelling that is not matched on the other side, a deep aching or cramping pain in the calf or thigh, warmth, tightness and sometimes a change in skin colour. It can also be quiet, producing little or nothing until it moves.
A pulmonary embolism announces itself in the chest, often with no warning from the leg at all: sudden shortness of breath, chest pain that sharpens when you breathe in, a racing heart, coughing that may bring up blood, light-headedness or collapse. Studies indicate that pulmonary embolism presents in many different ways and can resemble other chest and lung conditions, which is why clinicians rely on structured probability assessment rather than the symptom picture alone 6.
An embolus in a brain artery produces the stroke pattern: a drooping face, weakness in one arm, slurred or garbled speech, sudden loss of vision, all starting in an instant. An embolus in a limb artery produces a leg or arm that becomes suddenly painful, pale, cold and numb.
The shared thread is abruptness. A clot that has travelled tends to produce its effect in seconds to minutes, and all of the presentations above need emergency assessment, so call 911 rather than waiting to see whether it passes.
Risk rises with anything that slows blood flow, injures vessel walls or makes blood clot more readily, and most real-world risk comes from several of those stacking at once.
Reviews of venous thromboembolism risk group the contributors into inherited tendencies, such as a factor V Leiden variant, and acquired ones, such as major surgery, significant trauma, hospital admission, prolonged immobility, active cancer, increasing age, obesity, pregnancy and the period after it, hormonal factors and a previous clot 4. Research suggests that risk accumulates when an underlying tendency meets a temporary trigger, which is why a clot so often appears after an operation, a long period of bed rest or a long journey rather than out of nowhere 4.
It is worth separating two ideas here. A provoked clot has an identifiable trigger that has since passed. An unprovoked clot appears without one. Clinicians care about that distinction because it changes how they think about the chance of a repeat, and it is one of the things a licensed provider weighs when deciding what happens next for an individual person.
None of these factors is a verdict. Plenty of people carry several and never have a clot, and some people with none have one. What they do is shift probability, and knowing which ones apply to you is useful information to bring to a clinician, particularly before planned surgery or a long period of reduced movement.
Yes, inflammation and infection are associated with an increased tendency to venous thromboembolism 5.
The link runs through the lining of the blood vessels. When the immune system is activated, the endothelium shifts from a surface that discourages clotting to one that encourages it, immune cells release material that promotes clot formation, and the balance between clot building and clot breakdown tips. This overlap between immune defence and clotting is described as immunothrombosis, a response that helps wall off infection but can also produce clots where they are not wanted 5.
This is one reason an acute illness, a serious infection or a flare of an inflammatory condition is treated as a period of raised risk by clinicians, especially when it comes with bed rest or a hospital stay. It is also why several of the clotting proteins measurable on a blood panel rise during inflammation, which complicates interpretation. A single raised value drawn during or just after an illness may be reflecting the illness, not a persistent clotting tendency.
The practical takeaway for anyone reading their own labs is about timing. If a clotting-related marker comes back outside the standard range on a panel drawn while you were unwell, that context belongs in the conversation with your clinician, who may suggest repeating it once you have recovered.
Fibrinogen is the circulating protein that gets converted into the fibrin mesh holding any clot together, and Fibrinogen Activity measures how much functional clotting capacity is in your blood.
Labs typically regard 200 to 400 mg/dL as the reference range, and FitScript's optimal range is 200 to 300 mg/dL. Optimal ranges are optimization targets, not diagnostic cut-offs, and reference ranges vary by lab, age and sex.
Fibrinogen also rises as part of the acute phase response to inflammation, so a single elevated result can reflect a recent illness, injury or stress rather than a lasting tendency. It describes the raw material, not an event, and no value confirms or rules out a clot.
The dedicated marker guide covers the test itself, what moves the number and how to read a result in context.
Several markers describe different parts of the clotting system, and read together they give a fuller picture than any one of them alone.
Platelets are the cell fragments that form the initial plug, and a complete blood count reports both how many you have and how large they are on average. Coagulation timing tests such as PT, INR and aPTT measure how quickly the clotting cascade completes under laboratory conditions. D-dimer is a fragment released when fibrin is broken down, so it rises when clot is being formed and dissolved somewhere in the body, and it is used inside diagnostic pathways rather than as a screening test on its own 7. Inflammatory markers such as hs-CRP sit alongside these because of the overlap between immune activation and clotting.
A membership like FitScript tests 150+ biomarkers per year and has Atlas, its AI health advisor, interpret each result against the rest of your biology rather than in isolation, with any treatment decision left to a licensed provider who has reviewed you.
The useful habit is reading these as a pattern over time. One fibrinogen result slightly above the optimal range during a week you were fighting a chest infection tells you little. The same value appearing repeatedly across several draws, alongside raised inflammatory markers, is a pattern worth raising with a clinician.
Neither is diagnosed from a blood test alone. Diagnosis combines a structured assessment of how likely a clot is, selective blood testing and imaging of the vessel or organ in question.
The first step is clinical probability. A clinician scores symptoms, signs and risk factors to place you in a low, moderate or high likelihood group, because that score determines which test comes next 6. In lower probability situations, a D-dimer result that is not raised can help exclude a clot without imaging, while a raised result does not confirm one, since it climbs with infection, surgery, injury, pregnancy and age 7.
Imaging then looks at the suspected location. Compression ultrasound of the leg veins is the standard way to look for a deep vein thrombosis, and CT pulmonary angiography is the usual way to look for clot in the lung arteries 8. Alternatives exist when contrast or radiation is a concern, and an echocardiogram may be added to see how the right side of the heart is coping.
Diagnostic pathways that pair pretest probability with D-dimer are described as a way to reduce imaging that is unlikely to change the answer 8. The point for a reader is simple. A panel result cannot do this job, and a worrying symptom is not something to investigate by booking a blood test.
No. Clotting markers describe a tendency in your blood, not an event in your vessels, and no routine biomarker forecasts when or whether a clot will form.
It helps to separate the three layers. The observation is a number, for example a fibrinogen value sitting above the optimal range. What it may reflect is a system running with more clotting raw material than ideal, or ongoing inflammation, or both, since fibrinogen behaves as an acute phase protein. The next step is a conversation, because the meaningful question is whether that value is persistent, what the rest of the panel looks like, and what your personal risk factors are, particularly inherited ones or a previous clot.
What testing is genuinely good for is context and trend. Repeat measurement over time tells you whether something is a blip or a pattern. A broad panel shows whether a clotting marker is moving on its own or alongside inflammatory and metabolic markers. And a known family history or an inherited tendency is information a clinician can factor into planning around surgery, immobility or other temporary high risk periods.
What testing cannot do is replace symptoms. A normal panel in someone with a suddenly swollen painful leg changes nothing about the need for urgent assessment, and no result should ever be used to talk yourself out of getting checked.
Once a clot is confirmed, a licensed provider decides what happens next, based on where it is, how much strain it is putting on the circulation, your bleeding risk and whether the clot was provoked by a temporary trigger.
For pulmonary embolism in particular, clinicians use risk stratification, assessing blood pressure, heart rate, oxygen levels, signs of strain on the right side of the heart and other markers to sort people into groups that need different intensities of care and different settings, from hospital admission to outpatient management in selected lower risk cases 8. Management options, the length of time they continue and how they are monitored are all clinical decisions, and this guide deliberately does not go into specific therapies, because that judgement depends on the individual person in front of the clinician.
What is useful to know as a reader is that the questions a provider works through are predictable. Was there an obvious trigger. Is there a personal or family history of clots. What is your bleeding risk. Are there features suggesting an inherited clotting tendency worth testing for. Bringing clear answers to those questions, including any recent lab results, makes that consultation more productive.
Go straight to emergency care, calling 911, for sudden breathlessness, chest pain that worsens on breathing in, coughing up blood, fainting, one leg that is suddenly swollen, painful, warm or discoloured, a limb that turns cold and numb, or any face droop, one-sided weakness or slurred speech.
Those are the situations where time changes the outcome, and they are not situations to look into further first. Call emergency services.
A non-urgent conversation with a clinician is the right move in a different set of circumstances: a family history of clots in close relatives, a previous clot of your own, a clotting-related marker that stays outside the standard range on repeat testing, a planned operation or a long period of reduced movement ahead of you, or a result you simply do not understand. Any lab value that sits outside the standard range deserves a conversation rather than either panic or dismissal, and a value your clinician flags as needing prompt attention is worth discussing with them promptly.
This article is educational and is not medical advice. Discuss your own results and any treatment with a clinician or licensed provider who can see your full history.
No. Most emboli are fragments of a clot, but other materials can travel in the bloodstream and lodge in a narrower vessel, including fat after a major bone fracture, air entering through an open vein or line, clumps of tumour cells, infected material from a heart valve and cholesterol debris. The common feature is movement, not what the mass is made of.
Thromboembolism is the combined term for a clot that forms somewhere and then travels. Venous thromboembolism, often shortened to VTE, covers both deep vein thrombosis and pulmonary embolism, because clinicians regard them as two expressions of the same underlying problem rather than separate conditions.
No. Many deep vein clots stay where they are, and the body's own clot breakdown system works on them over time. Some do shed a fragment that reaches the lungs. There is no way to predict from symptoms alone which will do which, which is why a suspected leg clot is assessed promptly rather than watched at home.
Imaging does. Ultrasound of the leg veins is the usual way to look for a deep vein thrombosis, and a CT scan of the lung arteries is the usual way to look for a pulmonary embolism. Blood tests such as D-dimer are used alongside a clinician's assessment of how likely a clot is, not on their own.
No. Fibrinogen Activity measures the protein your body turns into the fibrin mesh of a clot, so it describes clotting raw material rather than whether a clot exists or will form. A result inside the standard range is reassuring context, nothing more. Symptoms always outrank a lab value.
Bring it to a clinician rather than acting on it yourself. Mention whether you were unwell, injured or recently had surgery when the sample was drawn, since several clotting markers rise temporarily with inflammation. Your clinician may suggest repeating the test later to see whether it is a one-off or a pattern.
Yes, testing for inherited clotting tendencies exists, but a clinician decides whether it is appropriate for you. It is usually considered when there is a clot at a young age, a clot without an obvious trigger, repeated clots, or a strong family history. The result changes how risk is managed, so it should be interpreted with a provider.
Call 911 for sudden shortness of breath, chest pain that worsens when you breathe in, coughing up blood, fainting, one leg that becomes suddenly swollen, painful or discoloured, a limb that turns cold and numb, or any face droop, one-sided weakness or slurred speech. These need emergency assessment immediately.